Author

F. Oudouhou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Baron· 2 shared B. Bessette· 1 shared B. Casu· 1 shared C. Gaudreau· 1 shared C. Morin· 1 shared J. Sygusch· 1 shared M. Bouin· 1 shared T. Arya· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Baron

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Inhibition of the type IV secretion system from antibiotic-resistant Helicobacter pylori clinical isolates supports the potential of Cagα as an anti-virulence target

F. Oudouhou, C. Morin, M. Bouin, C. Gaudreau, C. Baron

The paper investigates the genetic variability of the cagPAI in antibiotic-resistant H. pylori strains and shows that a small molecule inhibitor reduces interleukin-8 secretion and T4SS pili assembly.

bioRxiv · Sep 1, 2023 · PreprintMicrobiology

Fragment-based screening identifies inhibitors of the ATPase activity and of hexamer formation of Cagα from the Helicobacter pylori type IV secretion system

T. Arya, F. Oudouhou, B. Casu, B. Bessette, J. Sygusch, C. Baron

The paper identifies inhibitors of Cagα's ATPase activity and hexamer formation using fragment-based screening, revealing a novel mechanism for antivirulence drug development.

bioRxiv · May 20, 2018Microbiology